Potential Impact of KRAS Molecular Profiling of Non-Squamous Non-Small Cell Lung Cancer (NSCLC).

被引：1
|
作者：
Karim, N. [1 ]
Pathrose, J. [2 ]
Fathallah, H. [1 ]
El Desouki, I. [1 ]
Perry, A. [1 ]
Starnes, S. [3 ]
Morris, J. [1 ]
机构：
[1] Univ Cincinnati, Internal Med, Cincinnati, OH USA
[2] Univ Cincinnati, Mcmicken Coll Arts & Sci 1, Cincinnati, OH USA
[3] Univ Cincinnati, Surg, Cincinnati, OH USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
D O I：
10.1016/j.jtho.2018.08.1184
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.01-129
引用
收藏
页码：S714 / S715
页数：2
相关论文
共 50 条
  • [1] KRAS molecular profiling in non-squamous non-small cell lung cancer (NSCLC).
    Karim, Nagla Abdel
    Starnes, Sandra
    Morris, John
    Pathrose, Peter
    Perry, Ashley
    Fathallah, Hassana
    CLINICAL CANCER RESEARCH, 2014, 20
  • [2] Does Molecular Profiling of KRAS-Mutant Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Help in Treatment Strategy Planning?
    Karim, Nagla Abdel
    Ullah, Asad
    Pathrose, Peterson
    Fathallah, Hassana
    Perry, Ashley
    Morris, John C.
    Wang, Jiang
    Starnes, Sandra L.
    CURRENT ONCOLOGY, 2022, 29 (07) : 4779 - 4790
  • [3] Impact of reflex testing for EGFR mutations in non-squamous non-small cell lung cancer (NSCLC).
    Cheema, Parneet Kaur
    Victor, Charles
    Dolley, Aastha
    Dziarmaga, Alison
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [4] Maintenance chemotherapy in patients with non-squamous non-small cell lung cancer (NSCLC)
    Belalcazar, A.
    Santos, E. S.
    Gomez, J. E.
    Lopez, E.
    Raez, L. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [5] Impact of KRAS mutation on response and outcome of patients with stageIII non-squamous non-small cell lung cancer
    Yagishita, Shigehiro
    Horinouchi, Hidehito
    Sunami, Kuniko S.
    Kanda, Shintaro
    Fujiwara, Yutaka
    Nokihara, Hiroshi
    Yamamoto, Noboru
    Sumi, Minako
    Shiraishi, Kouya
    Kohno, Takashi
    Furuta, Koh
    Tsuta, Koji
    Tamura, Tomohide
    Ohe, Yuichiro
    CANCER SCIENCE, 2015, 106 (10) : 1402 - 1407
  • [6] Atezolizumab in non-squamous non-small cell lung cancer
    Akamine, Takaki
    Toyokawa, Gouji
    Tagawa, Tetsuzo
    Seto, Takashi
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S3155 - S3159
  • [7] Expanded molecular interrogation for potential actionable targets in non-squamous non-small cell lung cancer
    Lau, Kah Weng
    Seng, Claudia
    Lim, Tony K. H.
    Tan, Daniel S. W.
    ANNALS OF TRANSLATIONAL MEDICINE, 2017, 5 (18)
  • [8] Impact of Reflex Testing on Pathology Based Molecular Testing in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
    Marmarelis, M.
    Berman, A.
    Scholes, D.
    Thompson, J.
    Doucette, A.
    Gabriel, P.
    Bauml, J.
    Singh, A.
    Cohen, R.
    Litzky, L.
    Mcgrath, C.
    Feldman, M.
    Langer, C.
    Carpenter, E.
    Aggarwal, C.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1157 - S1157
  • [9] Utilization and clinical impact of genomic profiling for EGFR and ALK in non-squamous non-small cell lung cancer (NSCLC) in the community setting.
    Gutierrez, Martin
    Harper, Harry D.
    Halibey, Bohdan E.
    Miller, Vincent A.
    Conway, Jerry
    Oldroyd, Mark
    Choi, Kelly
    Schultz, Eric V.
    Pecora, Andrew
    Goldberg, Stuart L.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [10] Molecular landscape of non-squamous, non-small cell carcinoma of the lung
    Weiss, Mia C.
    Leukam, Michael J.
    Villaflor, Victoria M.
    TRANSLATIONAL CANCER RESEARCH, 2015, 4 (04) : 423 - 434
12345